Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7823303rdf:typepubmed:Citationlld:pubmed
pubmed-article:7823303lifeskim:mentionsumls-concept:C0153381lld:lifeskim
pubmed-article:7823303lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:7823303lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:7823303lifeskim:mentionsumls-concept:C0442040lld:lifeskim
pubmed-article:7823303pubmed:issue9lld:pubmed
pubmed-article:7823303pubmed:dateCreated1995-2-13lld:pubmed
pubmed-article:7823303pubmed:abstractTextSalivary polymorphonuclear leukocyte (SPMN) functions were examined in 18 patients with oral squamous cell carcinoma and in 20 healthy individuals. SPMN obtained from patients before therapy exhibited significantly less FMLP-stimulated chemotactic activity (132.4 +/- 17.5 cells/0.26 mm2) than that in SPMN from controls (177.1 +/- 11.6 cells/0.26 mm2), although no difference in phagocytosis was observed. When stimulated with PMA or FMLP, control SPMN generated superoxide (O2-) at levels of 50.3 +/- 10.5 pmol/min/10(4) cells and 88.4 +/- 15.4 pmol, respectively, while SPMN from untreated patients generated significantly reduced O2- in the presence of PMA or FMLP (24.3 +/- 3.5 pmol and 59.5 +/- 9.8 pmol, respectively). Only slightly lower chemiluminescence was observed in SPMN from untreated patients however, compared to controls, values being 68.0 +/- 18.9 vs 81.3 +/- 14.9 peak mV by PMA and 62.4 +/- 13.7 vs 64.4 +/- 12.9 peak mV by FMLP. Compared to Candida killing in control subjects (24.9 +/- 3.1%). SPMN from patients before treatment exhibited significantly reduced activity (18.7 +/- 4.9%). Further suppression of the SPMN functions examined was observed after chemoradio-therapy. Suppressed SPMN function in cancer patients, especially that associated with chemoradiotherapy, may therefore play a part in oral candidiasis.lld:pubmed
pubmed-article:7823303pubmed:languageenglld:pubmed
pubmed-article:7823303pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7823303pubmed:citationSubsetDlld:pubmed
pubmed-article:7823303pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7823303pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7823303pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7823303pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7823303pubmed:statusMEDLINElld:pubmed
pubmed-article:7823303pubmed:monthOctlld:pubmed
pubmed-article:7823303pubmed:issn0904-2512lld:pubmed
pubmed-article:7823303pubmed:authorpubmed-author:YamamotoTTlld:pubmed
pubmed-article:7823303pubmed:authorpubmed-author:YonedaKKlld:pubmed
pubmed-article:7823303pubmed:authorpubmed-author:OsakiTTlld:pubmed
pubmed-article:7823303pubmed:authorpubmed-author:UetaEElld:pubmed
pubmed-article:7823303pubmed:authorpubmed-author:UmazumeMMlld:pubmed
pubmed-article:7823303pubmed:issnTypePrintlld:pubmed
pubmed-article:7823303pubmed:volume23lld:pubmed
pubmed-article:7823303pubmed:ownerNLMlld:pubmed
pubmed-article:7823303pubmed:authorsCompleteYlld:pubmed
pubmed-article:7823303pubmed:pagination418-22lld:pubmed
pubmed-article:7823303pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:meshHeadingpubmed-meshheading:7823303-...lld:pubmed
pubmed-article:7823303pubmed:year1994lld:pubmed
pubmed-article:7823303pubmed:articleTitleInfluence of inductive chemoradiotherapy on salivary polymorphonuclear leukocyte (SPMN) functions in oral cancer.lld:pubmed
pubmed-article:7823303pubmed:affiliationDepartment of Oral Surgery, Kochi Medical School, Kohasu, Japan.lld:pubmed
pubmed-article:7823303pubmed:publicationTypeJournal Articlelld:pubmed